Trump Administration Buys 100 Million More Doses of Pfizer–BioNTech COVID-19 Vaccine

Boxes containing the first shipments of the Pfizer and BioNTech COVID-19 vaccine are unloaded from air shipping containers at UPS Worldport in Louisville, Ky., on Dec. 13, 2020. Michael Clevenger/Pool/Getty Images

The U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase an additional 100 million doses of the COVID-19 vaccine from Pfizer and BioNTech for delivery in 2021.

“Under the agreement, Pfizer will manufacture and deliver up to 100 million doses of its SARS-CoV-2 vaccine, BNT162b2, to Government designated locations,” a DOD statement on Dec. 23 states.